Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2007-4-12
pubmed:databankReference
pubmed:abstractText
The expression of interleukin-1-receptor antagonist is reduced in pancreatic islets of patients with type 2 diabetes mellitus, and high glucose concentrations induce the production of interleukin-1beta in human pancreatic beta cells, leading to impaired insulin secretion, decreased cell proliferation, and apoptosis.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Glucose Transporter Type 4, http://linkedlifedata.com/resource/pubmed/chemical/Heat-Shock Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist..., http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/PPARGC1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2007 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
356
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1517-26
pubmed:dateRevised
2008-6-10
pubmed:meshHeading
pubmed-meshheading:17429083-Blood Glucose, pubmed-meshheading:17429083-Body Mass Index, pubmed-meshheading:17429083-C-Reactive Protein, pubmed-meshheading:17429083-Diabetes Mellitus, Type 2, pubmed-meshheading:17429083-Double-Blind Method, pubmed-meshheading:17429083-Female, pubmed-meshheading:17429083-Gene Expression Regulation, pubmed-meshheading:17429083-Glucose Tolerance Test, pubmed-meshheading:17429083-Glucose Transporter Type 4, pubmed-meshheading:17429083-Heat-Shock Proteins, pubmed-meshheading:17429083-Hemoglobin A, Glycosylated, pubmed-meshheading:17429083-Humans, pubmed-meshheading:17429083-Insulin Resistance, pubmed-meshheading:17429083-Insulin-Secreting Cells, pubmed-meshheading:17429083-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:17429083-Interleukin-6, pubmed-meshheading:17429083-Male, pubmed-meshheading:17429083-Middle Aged, pubmed-meshheading:17429083-RNA, Messenger, pubmed-meshheading:17429083-Receptors, Interleukin-1, pubmed-meshheading:17429083-Recombinant Proteins, pubmed-meshheading:17429083-Transcription Factors
pubmed:year
2007
pubmed:articleTitle
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
pubmed:affiliation
Steno Diabetes Center, Gentofte, Denmark.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study